Robuta

https://www.spandidos-publications.com/10.3892/ol.2023.14127 Dihydroartemisinin inhibits liver cancer cell migration and invasion by reducing ATP synthase... Oncology Letters is an international journal devoted to Experimental and Clinical Oncology. liver cancercell migration https://pmc.ncbi.nlm.nih.gov/articles/PMC7261662/ Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1... Leukemia threatens so many lives around the world. Dihydroartemisinin (DHA), as a typical derivative of artemisinin (ART), can efficiently inhibit leukemia,... https://pmc.ncbi.nlm.nih.gov/articles/PMC4718674/ Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous... Developing drugs that can effectively block STAT3 activation may serve as one of the most promising strategy for cancer treatment. Currently, there is no... https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.949835/full Frontiers | Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated... Lung cancer recruits tumor-associated macrophages (TAM) massively, whose predominantly pro-tumor M2 phenotype leads to immunosuppression. Dihydroartemisinin ... frontiersdihydroartemisininremodelsmacrophage https://www.gov.uk/research-for-development-outputs/an-open-label-randomised-study-of-dihydroartemisinin-piperaquine-versus-artesunate-mefloquine-for-falciparum-malaria-in-asia An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for... open label https://pmc.ncbi.nlm.nih.gov/articles/PMC8226784/ Dihydroartemisinin Inhibits mTORC1 Signaling by Activating the AMPK Pathway in Rhabdomyosarcoma... Dihydroartemisinin (DHA), an anti-malarial drug, has been shown to possess potent anticancer activity, partly by inhibiting the mammalian target of rapamycin... dihydroartemisininmtorc1signaling https://pmc.ncbi.nlm.nih.gov/articles/PMC4370589/ Dihydroartemisinin Inhibits Glucose Uptake and Cooperates with Glycolysis Inhibitor to Induce... Despite recent advances in the therapy of non-small cell lung cancer (NSCLC), the chemotherapy efficacy against NSCLC is still unsatisfactory. Previous studies... glucose uptakedihydroartemisinin